Skip to content
TrialScanner

NCT02188160

Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease

Phase 2CompletedKALALead

Registry record

Lead sponsor
Kala Pharmaceuticals, Inc.
Conditions
Dry Eye Syndromes; Keratoconjunctivitis Sicca
Primary completion
Jan 2015Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02188160 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02188160: Safety and Efficacy of... | TrialScanner